Hantz Financial Services’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32K Buy
1,302
+178
+16% +$4.17K ﹤0.01% 1807
2026
Q1
$16K Buy
1,124
+9
+0.8% +$121 ﹤0.01% 1929
2025
Q4
$13K Buy
1,115
+768
+221% +$8.79K ﹤0.01% 1922
2025
Q3
$4K Buy
347
+147
+74% +$1.72K ﹤0.01% 2043
2025
Q2
$2K Buy
+200
New +$2.52K ﹤0.01% 1948

Other funds holding AVNS

Hantz Financial Services's AVNS Position: Q2 2026 in Review

Hantz Financial Services increased its Avanos Medical (AVNS) stake by 16% in Q2 2026, buying an estimated $4.17K and bringing the position to 1,302 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Hantz Financial Services first reported a position in AVNS in Q2 2025 and has held it in 5 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Hantz Financial Services held 1,302 shares of Avanos Medical worth $32K as of Q2 2026.
  • Hantz Financial Services bought 178 Avanos Medical shares in Q2 2026, an estimated $4.17K.
  • Avanos Medical made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1807 holding.
  • Hantz Financial Services first reported a position in Avanos Medical in Q2 2025 and has held it in 5 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.